Study to Evaluate Safety and PK/PD of DA-3091 in Healthy Male Subjects
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This Phase I clinical study is to evaluate the safety and tolerance of DA-3091 and to
characterize the pharmacokinetic/pharmacodynamic of DA-3091 in healthy male subjects